Safety and Immunogenicity Study of Fluval AB-Like Flu Vaccines With 3.5, 6, 9 or 15 μg HA in Adult and Elderly People

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01408290
Recruitment Status : Completed
First Posted : August 3, 2011
Last Update Posted : May 21, 2012
Information provided by (Responsible Party):
Fluart Innovative Vaccine Ltd, Hungary

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2011
  Actual Study Completion Date : October 2011